GlobalDeal

Intercept Pharmaceuticals

Pharmaceuticals · Morristown, United States

interceptpharma.com

About Intercept Pharmaceuticals

Intercept Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat liver diseases. The company's lead product, Ocaliva (obeticholic acid), is approved for the treatment of primary biliary cholangitis (PBC) and is being investigated for other liver-related conditions. Intercept is committed to addressing unmet medical needs in the field of liver health through innovative research and development. The company operates with a strong emphasis on scientific rigor and patient-centric approaches, aiming to improve the quality of life for patients suffering from chronic liver diseases.

Company facts

Industry
Pharmaceuticals
Sub-industries
Biopharmaceuticals, Liver Diseases, Drug Development, Therapeutics, Clinical Research
Location
Morristown, United States
Employees
11–50
Revenue (USD)
1–5M
Founded
2002

Products and services

Open Intercept Pharmaceuticals in GlobalDeal Is this your company? Update the details for free

More Pharmaceuticals companies in United States

All 12,119 Pharmaceuticals companies in United States →